VEGFA and infection: Consistent with a review of safety incidents relating to ocular anti-vascular endothelial growth factor injections, delays were among the severe causes of harm identified, alongside intraocular inflammation or infection, with recommendations put forward involving system level planning, checklists and electronic records [34].